SCHEMBL4617353

SCHEMBL4617353

Cc1cc(Oc2ccc(CCC(=O)O)c(C)c2)cc([C@@H](C)NC(=O)c2[nH]c3ccc(F)cc3c2C)c1

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARG P37231 9/20 0.52
PPARD Q03181 9/20 0.52
PPARA Q07869 9/20 0.52
CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5409416 1.00 PPARG (0.52) PPARGPPARDPPARACNR1
SCHEMBL4617126 0.94 PPARG (0.55) PPARGPPARDPPARACNR1
SCHEMBL4615888 0.94 PPARG (0.55) PPARGPPARDPPARACNR1
SCHEMBL4616280 0.94 PPARG (0.55) PPARGPPARDPPARACNR1
SCHEMBL4616881 0.93 PPARG (0.59) PPARGPPARDPPARACNR1
SCHEMBL4614612 0.93 PPARG (0.45) PPARGPPARDPPARACNR1
SCHEMBL4616877 0.93 PPARG (0.59) PPARGPPARDPPARACNR1
SCHEMBL4666589 0.91 PPARG (0.59) PPARGPPARDPPARACNR1
SCHEMBL4666592 0.91 PPARG (0.59) PPARGPPARDPPARACNR1
SCHEMBL4616307 0.88 PPARG (0.64) PPARGPPARDPPARACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1697304-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2008-02-20 EP disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
EP-1697304-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2006-09-06 EP disclosed
WO-2005054176-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082907-A1 Peroxisome proliferator activated receptor modulators PPARG, PPARA, PPARD PPARG 1/4885PPARD 3/4885PPARA 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.